VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
HCl liquid
Preclinical
Small molecule
N
National Research Centre, Egypt
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Preclinical
Completed
Clinical
Trials by Indication
[1]
White Spot Lesions
1 trial
Effect of Nanohydroxyapatite Paste After Different Pretreatment Techniques on White Spot White Spot Lesions
Completed
·
N
National Research Centre, Egypt
·
N/A
·
NCT06834464
·
40 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for HCl liquid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
HCl liquid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for HCl liquid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
National Research Centre, Egypt company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
N
National Research Centre, Egypt
Related News